Why is quinoa getting a free pass?

A day doesn’t pass that I don’t see some new “healthy” recipe for quinoa, or a dietitian or nutritionist gushing about the health benefits of this seed. Many make the claim that quinoa is high in protein and is gluten-free. Clearly, the gluten-free movement is fueling some of this excitement over  this seed. But how much truth are there in these claims? And just how healthy is quinoa as a replacement for grains? Let’s tackle these claims one by one: Quinoa is not a grain and is gluten-free This is absolutely true. While all grains, or seeds of grasses, are members of the family Poaceae, quinoa is not; it is a member of the family Amaranthaceae that includes spinach, beets, and some ornamental shrubs. It therefore does not have the gluten proteins of wheat, rye, or barley, nor anything resembling the zein protein of corn nor the avenin of oats. From this perspective, quinoa is therefore safe for people, for instance, with celiac disease. Quinoa is high in protein I have always been puzzled by this popular claim. The claim of “high” is relative, of course. Quinoa contains 14 grams protein per 100 grams total weight. Wheat contains 14-18 grams, oats 16.9 grams, though barley contains 9.9 grams and millet 11 grams. So quinoa is middling if grains are the comparator. Quinoa is healthy No question: quinoa lacks the worst aspects of wheat and its brethren grains, such as the gliadin protein that initiates autoimmune diseases and, upon p...
Source: Wheat Belly Blog - Category: Cardiology Authors: Tags: Wheat Belly Lifestyle blood sugar carbohydrates carbs gluten-free quinoa Source Type: blogs

Related Links:

Publication date: Available online 10 November 2019Source: Science &SportsAuthor(s): X. BigardRésuméObjectifsLa nutrition joue un rôle indéniable pour l’excellence des performances dans les sports d’endurance. Les réserves en glucose de l’organisme sous forme de glycogène étant limitées, toute épargne du glycogène et tout substrat alternatif au glucose peuvent être utiles pour les performances. C’est ainsi que ces dernières années, les stratégies nutritionnelles destinées à augmenter la ...
Source: Science and Sports - Category: Sports Medicine Source Type: research
Authors: German C, Yeboah J PMID: 31703538 [PubMed - as supplied by publisher]
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
ConclusionsMRI may offer more superior diagnostic performance than CT for detecting T3-4 disease and EMVI, thereby supporting its alternative application to CT in local staging of colon cancer.
Source: European Journal of Radiology - Category: Radiology Source Type: research
tro V Abstract Immunotherapy has been showed as a promisor treatment, in special for hematological diseases. Chimeric antigen receptor T cells (CARs) which are showing satisfactory results in early-phase cancer clinical trials can be highlighted. However, preclinical models are critical steps prior to clinical trial. In this way, a well-established preclinical model is an important key in order to confirm the proof of principle. For this purpose, in this chapter will be pointed the methods to generate tumor cells expressing firefly Luciferase. In turn, these modified cells will be used to create a subcutaneous and...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
Abstract Chimeric antigen receptor (CAR) T cell therapies are ex vivo manufactured cellular products that have been useful in the treatment of blood cancers and solid tumors. The quality of the final cellular product is influenced by several amenable factors during the manufacturing process. This review discusses several of the influences on cell product phenotype, including the raw starting material, methods of activation and transduction, and culture supplementation. PMID: 31707678 [PubMed - in process]
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
m KCR Abstract CAR-T cell immunotherapy is a promising therapeutic modality for cancer patients. The success of CAR-T cell therapy has been associated with the phenotype, activation and functional profiling of infused CAR-T cells. Therefore, immunophenotypic characterization of CAR-T cells during bioprocess is crucial for cell quality control and ultimately for improved antitumor efficacy. In this chapter, we propose a flow cytometry panel to characterize the immunophenotype of the CAR-T subsets. PMID: 31707677 [PubMed - in process]
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
Abstract Lentiviral vectors are being used in a growing number of clinical applications, including T cell immunotherapy for cancer. As this new technology moves forward, a safety concern is the inadvertent recombination and subsequent development of a replication-competent lentivirus (RCL) during the manufacture of the vector material. To assess this risk, regulators have required screening of T cell products infused into patients for RCL. Since vector particles have many of the proteins and nucleotide sequences found in RCL, a biologic assay has proven the most sensitive method for RCL detection. As regulators ha...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
Abstract Adoptive immunotherapy of cancer using T cells expressing chimeric antigen receptors (CARs) is now an approved treatment for non-Hodgkin lymphoma (NHL) and B cell acute lymphoblastic leukemia (B-ALL), inducing high response rates in patients. The infusion products are generated by using retro- or lentiviral transduction to induce CAR expression in T cells followed by an in vitro expansion protocol. However, use of viral vectors is cumbersome and is associated with increased costs due to the required high titers, replication-competent retrovirus (RCR) detection and production/use in a biosafety level 2 cul...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
Abstract Chimeric antigen receptor (CAR) cancer immunotherapy uses autologous immune system's cells, genetically modified, to reinforce the immune system against cancer cells. Genetic modification is usually mediated via viral transfection, despite the risk of insertional oncogenesis and off target side effects. In vitro-transcribed (IVT)-mRNA-mediated transfection could contribute to a much safer CAR therapy, since IVT-mRNA leaves no ultimate genetic residue in recipient cells. In this chapter, the IVT-mRNA generation procedure is described, from the selection of the target of the CAR T-cells, the cloning of the ...
Source: Mol Biol Cell - Category: Molecular Biology Authors: Tags: Methods Mol Biol Source Type: research
Ben shared his 3-week experience living the Wheat Belly lifestyle after being diagnosed with celiac disease: “My family doctor diagnosed me with celiac and wheat allergies. These pictures were taken 3 weeks apart: prior to the diagnosis and three weeks later, a photo of me after following the Wheat Belly books that my doctor recommended I get. “I still feel like I eat like a king. I am just a lot more cautious about what I put into my body and I am seeing the results!” You can see that Ben’s face shows the changes we expect to see as inflammation recedes: reduced cheek and around-the-eyes edema, la...
Source: Wheat Belly Blog - Category: Cardiology Authors: Tags: Wheat Belly Success Stories celiac gluten grains Inflammation Source Type: blogs
More News: Autoimmune Disease | Blogging | Calcium | Cancer | Cancer & Oncology | Carbohydrates | Cardiology | Cataracts | Celiac Disease | Coeliac Disease | Dementia | Diets | Gastroenterology | Gluten | Heart | Heart Disease | Hypertension | Insulin | Iron | Magnesium | Nutrition | Quinoa | Skin | Spinach | Sugar | Wheat | Zinc